Nn9536-4999
Research payments
$11,426,533
Through program year 2025, $11,426,533 in research payments was reported against Nn9536-4999, across 10,781 payments, paid by Novo Nordisk AS.
- Paid by
- Novo Nordisk AS
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $719,611 | 73 |
| 2024 | Research | $4,405,341 | 1,719 |
| 2023 | Research | $6,254,420 | 6,587 |
| 2022 | Research | $47,161 | 2,402 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Humberto Cruz Orlando, FL Named on 622 payments
- Julio Rosenstock Dallas, TX Named on 618 payments
- Ildiko Lingvay Dallas, TX Named on 611 payments
- Faith Holmes Austin, TX Named on 580 payments
- Mark Christiansen Walnut Creek, CA Named on 561 payments
- John Buse Chapel Hill, NC Named on 423 payments
- Cindy Ta Honolulu, HI Named on 413 payments
- Alexander Murray Greensboro, NC Named on 401 payments
- Phillip Toth Indianapolis, IN Named on 367 payments
- Darlene Bartilucci Jacksonville, FL Named on 330 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.